The canonical role of Bcl-xL as an anti-apoptotic factor in melanoma was fully elucidated in a recent study by Erinna F. Lee et al. [100], with the aim of evaluating the role that the different components of the Bcl-2 family play in melanoma. This evidence concerns the gene BCL2 and melanoma.